540
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      BACE1 Processing of NRG1 Type III Produces a Myelin-Inducing Signal but Is Not Essential for the Stimulation of Myelination

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Myelin sheath thickness is precisely adjusted to axon caliber, and in the peripheral nervous system, neuregulin 1 (NRG1) type III is a key regulator of this process. It has been proposed that the protease BACE1 activates NRG1 dependent myelination. Here, we characterize the predicted product of BACE1-mediated NRG1 type III processing in transgenic mice. Neuronal overexpression of a NRG1 type III-variant, designed to mimic prior cleavage in the juxtamembrane stalk region, induces hypermyelination in vivo and is sufficient to restore myelination of NRG1 type III-deficient neurons. This observation implies that the NRG1 cytoplasmic domain is dispensable and that processed NRG1 type III is sufficient for all steps of myelination. Surprisingly, transgenic neuronal overexpression of full-length NRG1 type III promotes hypermyelination also in BACE1 null mutant mice. Moreover, NRG1 processing is impaired but not abolished in BACE1 null mutants. Thus, BACE1 is not essential for the activation of NRG1 type III to promote myelination. Taken together, these findings suggest that multiple neuronal proteases collectively regulate NRG1 processing. © 2011 Wiley Periodicals, Inc.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

          Schizophrenia is a highly debilitating mental disorder that affects approximately 1% of the general population, yet it continues to be poorly understood. Recent studies have identified variations in several genes that are associated with this disorder in diverse populations, including those that encode neuregulin 1 (NRG1) and its receptor ErbB4. The past few years have witnessed exciting progress in our knowledge of NRG1 and ErbB4 functions and the biological basis of the increased risk for schizophrenia that is potentially conferred by polymorphisms in the two genes. An improved understanding of the mechanisms by which altered function of NRG1 and ErbB4 contributes to schizophrenia might eventually lead to the development of more effective therapeutics.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Neuregulins: functions, forms, and signaling strategies

              D Falls (2003)
              The neuregulins (NRGs) are cell-cell signaling proteins that are ligands for receptor tyrosine kinases of the ErbB family. The neuregulin family of genes has four members: NRG1, NRG2, NRG3, and NRG4. Relatively little is known about the biological functions of the NRG2, 3, and 4 proteins, and they are considered in this review only briefly. The NRG1 proteins play essential roles in the nervous system, heart, and breast. There is also evidence for involvement of NRG signaling in the development and function of several other organ systems, and in human disease, including the pathogenesis of schizophrenia and breast cancer. There are many NRG1 isoforms, raising the question "Why so many neuregulins?" Study of mice with targeted mutations ("knockout mice") has demonstrated that isoforms differing in their N-terminal region or in their epidermal growth factor (EGF)-like domain differ in their in vivo functions. These differences in function might arise because of differences in expression pattern or might reflect differences in intrinsic biological characteristics. While differences in expression pattern certainly contribute to the observed differences in in vivo functions, there are also marked differences in intrinsic characteristics that may tailor isoforms for specific signaling requirements, a theme that will be emphasized in this review.
                Bookmark

                Author and article information

                Journal
                Glia
                glia
                Glia
                Wiley Subscription Services, Inc., A Wiley Company (Hoboken )
                0894-1491
                1098-1136
                February 2012
                02 November 2011
                : 60
                : 2
                : 203-217
                Affiliations
                [1 ]simpleDepartment of Neurogenetics, Max-Planck-Institute of Experimental Medicine Goettingen, Germany
                [2 ]simpleDivision of Neuroscience and INSPE, San Raffaele Scientific Institute Milan, Italy
                [3 ]simpleDZNE-German Center for Neurodegenerative Diseases Munich, Germany
                [4 ]simpleBiochemistry, Adolf-Butenandt-Institute, Ludwig-Maximilians-University Munich, Germany
                Author notes
                *Correspondence to: Markus H. Schwab, Department of Neurogenetics, Max-Planck-Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075 Goettingen, Germany. E-mail: schwab@ 123456em.mpg.de or Klaus-Armin Nave, Department of Neurogenetics, Max-Planck-Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075 Goettingen, Germany. E-mail: nave@ 123456em.mpg.de .

                Additional Supporting Information may be found in the online version of this article.

                Grant sponsors: DFG Research Center for Molecular Physiology of the Brain (CMPB), the National Multiple Sclerosis Society, an EC Neuroscience Early Stage Researcher Training (NEUREST), HELMA (Helmholtz Alliance for Mental health and Ageing), and NGFNplus; Grant sponsor: Federazione Italiana Sclerosi multipla; Grant number: FISM 2007/PC/01; Grant sponsor: Fondazione Telethon; Grant number: GPP10007.

                Article
                10.1002/glia.21255
                3267053
                22052506
                ad895978-5d7d-4d4c-85c1-95a90d096d9f
                Copyright © 2011 Wiley Periodicals, Inc.

                Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.

                History
                : 24 June 2011
                : 21 September 2011
                Categories
                Original Research Articles

                Neurosciences
                pns,axon,growth factor,schwann cell
                Neurosciences
                pns, axon, growth factor, schwann cell

                Comments

                Comment on this article